The three-building facility enables JN to expand its ability to increase vaccine supplies. The move is intended to help reduce time to market for the company's Meningococcal meningitis serotypes A, C, Y and W-135.
Companies in this article
JN-Intl. acquires vaccine facilities from Pfizer
Biopharmaceutical firm JN Intl.acquired Biocor, a subsidiary of Pfizer, Inc.
Jun 2, 2009
How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
